Literature DB >> 21375315

Total syntheses of (-)- and (+)-goniomitine.

Masaya Mizutani1, Fuyuhiko Inagaki, Takeo Nakanishi, Chihiro Yanagihara, Ikumi Tamai, Chisato Mukai.   

Abstract

The Stille coupling reaction of 3-(benzyloxymethyl)-1-(tert-butyldiphenylsiloxy)ethyl-1-(tributylstannyl)allene with N-(tert-butoxycarbonyl)-2-iodoaniline directly produced the corresponding 2-vinylindole derivative, which was independently transformed into natural (-)-goniomitine and unnatural (+)-goniomitine via the cross-metathesis with chiral oxazolopiperidone lactams. The antiproliferative activity of the synthesized natural (-)-goniomitine in Mock and MDCK/MDR1 cells showed them to be more potent to retard cell growth than unnatural (+)-goniomitine.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21375315     DOI: 10.1021/ol200320z

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  5 in total

1.  A FISCHER INDOLIZATION STRATEGY TOWARD THE TOTAL SYNTHESIS OF (-)-GONIOMITINE.

Authors:  Beau P Pritchett; Jun Kikuchi; Yoshitaka Numajiri; Brian M Stoltz
Journal:  Heterocycles       Date:  2017-02-15       Impact factor: 0.831

2.  Enantioselective Pd-Catalyzed Allylic Alkylation Reactions of Dihydropyrido[1,2-a]indolone Substrates: Efficient Syntheses of (-)-Goniomitine, (+)-Aspidospermidine, and (-)-Quebrachamine.

Authors:  Beau P Pritchett; Jun Kikuchi; Yoshitaka Numajiri; Brian M Stoltz
Journal:  Angew Chem Int Ed Engl       Date:  2016-09-26       Impact factor: 15.336

Review 3.  Goniomitine: an overview on the chemistry of this indole alkaloid.

Authors:  José C F Alves
Journal:  ISRN Org Chem       Date:  2013-12-23

4.  Asymmetric construction of pyrido[1,2-a]-1H-indole derivatives via a gold-catalyzed cycloisomerization.

Authors:  Feng Jiang; Chunling Fu; Shengming Ma
Journal:  Chem Sci       Date:  2020-10-22       Impact factor: 9.825

5.  Propargyltrimethylsilanes as allene equivalents in transition metal-catalyzed [5 + 2] cycloadditions.

Authors:  Paul A Wender; Fuyuhiko Inagaki; Magnus Pfaffenbach; Matthew C Stevens
Journal:  Org Lett       Date:  2014-05-12       Impact factor: 6.005

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.